For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of ...

The brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this ...

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

Each year in the U.S., approximately 2.5 million people suffer traumatic brain injuries (TBIs). About 50,000 of these injuries will result in death, and more than 80,000 will lead to permanent ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...